41722 Federal Register / Vol. 87, No. 133 / Wednesday, July 13, 2022 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2022–0083] 

Advisory Committee to the Director, 

Centers for Disease Control and 

Prevention 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

of the Advisory Committee to the 

Director, Centers for Disease Control 

and Prevention (ACD, CDC). This is a 

hybrid meeting, accessible both in 

person and virtually (webcast live via 

the World Wide Web). It is open to the 

public and limited only by the space 

available. Time will be available for 

public comment. 

DATES: The meeting will be held on 

August 9, 2022, from 9:00 a.m. to 2:30 

p.m., EDT (times subject to change). 

Written comments must be received 

on or before August 1, 2022. 

ADDRESSES: 

Meeting address: CDC Roybal 

Campus, Building 19, Rooms 247 and 

248, 1600 Clifton Road NE, Atlanta, 

Georgia 30329–4027. The conference 

rooms combine to accommodate 

approximately 45 people. 

Please note that the meeting location, 

the CDC Roybal Campus, is a federal 

facility and in-person access is limited 

to United States citizens unless prior 

authorizations, taking up to 30 to 60 

days, have been made. Visitors must 

follow all directions for access to CDC 

facilities. Directions for visitors to CDC, 

including COVID–19 vaccination and 

testing guidelines, are available at 

https://www.cdc.gov/screening/ 

visitors.html. 

Registration: You must register to 

attend this meeting in person. If you 

wish to attend in person, please submit 

a request by email to ACDirector@

cdc.gov or by telephone at (404) 639– 

7000 at least 5 business days in advance 

of the meeting. No registration is 

required to view the meeting via the 

World Wide Web. Information for 

accessing the webcast will be available 

at https://www.cdc.gov/about/advisorycommittee-director/. 

Written comments: You may submit 

comments, identified by Docket No. 

CDC–2022–0083, by either of the 

methods listed below. Do not submit 

comments for the docket by email. CDC 

does not accept comments for the 

docket by email. 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Kerry Caudwell, MPA, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, 

Mailstop H21–10, Atlanta, Georgia 

30329–4027. Attn: Docket No. CDC– 

2022–0083. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to https://www.regulations.gov, 

including any personal information 

provided. For access to the docket to 

read background documents or 

comments received, go to https://

www.regulations.gov. Written comments 

received in advance of the meeting will 

be included in the official record of the 

meeting. 

FOR FURTHER INFORMATION CONTACT: 

Kerry Caudwell, MPA, Office of the 

Chief of Staff, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, Mailstop H21–10, Atlanta, 

Georgia 30329–4027; Telephone: (404) 

639–7000; Email: ACDirector@cdc.gov. 

SUPPLEMENTARY INFORMATION:

Purpose: The Advisory Committee to 

the Director, CDC, shall advise the 

Secretary, HHS, and the Director, CDC, 

on policy and broad strategies that will 

enable CDC to fulfill its mission of 

protecting health through health 

promotion, prevention, and 

preparedness. The committee 

recommends ways to prioritize CDC’s 

activities, improve results, and address 

health disparities. It also provides 

guidance to help CDC work more 

effectively with its various private and 

public sector constituents to make 

health protection a practical reality. 

Matters To Be Considered: The 

agenda will include discussions 

regarding CDC’s current and future work 

in the following topic areas: (1) data 

modernization; (2) laboratory quality; 

and (3) health equity. The ACD will 

hear reports from its working groups on 

these three topics. In addition, the ACD 

will hear an update on climate change 

and health. Agenda items are subject to 

change as priorities dictate. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. Oral 

public comment will occur before any 

scheduled votes. Priority will be given 

to individuals who submit a request to 

make an oral public comment before the 

meeting according to the procedure 

below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the August 9, 2022, 

ACD meeting must submit a request by 

visiting https://www.cdc.gov/about/ 

advisory-committee-director/ no later 

than 11:59 p.m., EDT, August 1, 2022, 

according to the instructions provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

by August 3, 2022. To accommodate the 

significant interest in participation in 

the oral public comment session of ACD 

meetings, each speaker will be limited 

to 2 minutes, and each speaker may 

only speak once per meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 133 / Wednesday, July 13, 2022 / Notices 41723 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–14932 Filed 7–12–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[OMB #0970–0531] 

Submission for OMB Review; 

Formative Data Collections for ACF 

Program Support 

AGENCY: Office of Planning, Research, 

and Evaluation, Administration for 

Children and Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Administration for 

Children and Families (ACF) plans to 

submit a request to the Office of 

Management and Budget (OMB) to 

extend approval of the existing 

overarching generic clearance for 

Formative Data Collections for ACF 

Program Support (OMB #0970–0531; 

expiration date 7/31/2022). ACF 

proposes minor updates to the 

description of potential generic 

information collections under the 

overarching generic and to the estimated 

number of respondents. 

DATES: Comments due within 30 days of 

publication. OMB must make a decision 

about the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. You can also obtain 

copies of the proposed collection of 

information by emailing 

OPREinfocollection@acf.hhs.gov. 

Identify all requests by the title of the 

information collection. 

SUPPLEMENTARY INFORMATION: 

Description: The goals of the generic 

information collections under this 

approval are to obtain information about 

program and grantee processes or needs 

and to inform the following types of 

activities, among others: 

• Delivery of targeted assistance and/ 

or workflows related to program and 

grantee processes. This could include 

the development and refinement of 

recordkeeping and communication 

systems. 

• Planning for provision of 

programmatic or evaluation-related 

training or technical assistance (T/TA). 

• Obtaining input on the 

development of program performance 

measures from grantees or others with 

experience or vested interest. 

• Obtaining feedback about processes 

and/or practices to inform ACF program 

development or support, or ACF 

research. 

• Use of rapid-cycle testing activities 

to strengthen programs in preparation 

for summative evaluations. 

• Creating public resources with 

information about ACF-funded 

programs, systems, or activities. 

ACF uses a variety of techniques such 

as semi-structured discussions, focus 

groups, surveys, templates, open-ended 

requests, and telephone or in-person 

interviews in order to reach these goals. 

Information collected under this 

overarching generic is meant to inform 

ACF activities and may be incorporated 

into documents or presentations that are 

made public such as through conference 

presentations, websites, or social media. 

The following are some examples of 

ways in which we may share 

information resulting from these data 

collections: technical assistance plans, 

presentations, infographics, project 

specific reports, or other documents 

relevant to those involved with or 

interested in ACF programs such as 

federal leadership and staff, grantees, 

local implementing agencies, and/or T/ 

TA providers. 

Information may also be used to 

create public resources for users 

(clients, programs, researchers). 

Following standard OMB requirements, 

the Office of Planning, Research, and 

Evaluation will submit a change request 

for each individual data collection 

activity under this generic clearance. 

Each request will include the individual 

instrument(s), a justification specific to 

the individual information collection, 

and any supplementary documents. 

OMB should review requests within 10 

days of submission. 

The proposed types and the purpose 

of generic information collections 

submitted under this umbrella generic 

remain the same. Minor revisions are 

based on experiences over the past 3 

years. These include: 

• Updated burden estimates 

• Broadened the description to make 

clearer the intention to broadly include 

respondents with knowledge, 

experience, or interest in ACF programs 

to allow ACF to learn about needs and 

processes related to ACF programs from 

those not necessarily funded by ACF 

• Included specification about 

requesting information for efforts to 

consolidate publicly available 

information to build public resources 

for ACF programs, grantees, clients, or 

others who may use or be interested in 

services funded by ACF. 

Respondents: Example respondents 

include current or prospective service 

providers, training or T/TA providers, 

grantees, contractors, current and 

potential participants in ACF programs 

or similar comparison groups, experts in 

fields pertaining to ACF programs, key 

groups involved in ACF projects and 

programs, individuals engaged in 

program re-design or demonstration 

development for evaluation, state or 

local government officials, or others 

involved in or prospectively involved in 

ACF programs. 

Burden Estimates 

At the time of this extension request, 

30 GenICs are ongoing, with a total of 

13,652 burden hours. See Attachment B 

for a list of all previously approved, 

ongoing GenICs. The following 

estimates are specific to new collections 

over the next three years. 

Instrument 

Number of 

respondents 

(total over 

request 

period) 

Number of 

responses per 

respondent 

(total over 

request 

period) 

Average 

burden 

per response 

(in hours) 

Total burden 

(in hours) 

Semi-Structured Discussions and Focus Groups ............................................ 10,000 1 2 20,000 

Interviews ......................................................................................................... 4,500 1 1 4,500 

Questionnaires/Surveys ................................................................................... 8,000 1.5 .5 6,000 


jspears on DSK121TN23PROD with NOTICES1